https://www.newpharmaitaly.it/invivoscribe-submits-leukostrat-cdx-flt3-mutation-assay-to-nmpa-in-china-and-expands-company-adding-laboratory-in-shanghai-to-provide-comprehensive-support-for-partners/ Il portale delle news in ambito farmaceutico Tue, 12 May 2020 08:01:27 +0000 hourly 1 https://wordpress.org/?v=7.0